Health FDA Approves Romvimza: New Oral Treatment for Rare Joint TumorBy Stanley SimalsFebruary 20, 2025 Health 3 Mins Read The FDA has approved vimseltinib, a new oral medication designed to treat tenosynovial giant cell tumor (TGCT), a rare, noncancerous…
Health FDA Approves Vimseltinib for Non-Surgical Treatment of Tenosynovial Giant Cell TumorsBy Stanley SimalsFebruary 16, 2025 Health 3 Mins Read The FDA has approved vimseltinib for the treatment of adult patients with symptomatic tenosynovial giant cell tumors (TGCT) who are…
